Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting-Reference-Cited by-同舟云学术

Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting

Published:2016-07 Issue: Volume:159 Page:211-218
ISSN:0001-706X
Container-title:Acta Tropica
language:en
Short-container-title:Acta Tropica

Author:

Fakhraee Fatemeh,Badiee Ali,Alavizadeh Seyedeh Hoda,Jalali Seyed Amir,Chavoshian Omid,Khamesipour Ali,Mahboudi Fereidoun,Jaafari Mahmoud Reza

Funder

Biotechnology Research Center and Pharmaceutical Research Center

Mashhad University of Medical Sciences (MUMS)

Center for Research and Training in Skin Diseases and Leprosy

Tehran University of Medical Sciences (TUMS)

Nanotechnology Research Center, MUMS, Iran

Publisher

Elsevier BV

Subject

Infectious Diseases,Parasitology,Insect Science,Veterinary (miscellaneous)

Reference61 articles.

1. The role of liposome–protamine–DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice;Alavizadeh;Exp. Parasitol.,2012

2. T helper (h) 1/Th2 and Leishmania: paradox rather than paradigm;Alexander;Immunol. Lett.,2005

3. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends;Badiee;Vaccine,2013

4. Recent developments in leishmaniasis vaccine delivery systems;Bhowmick;Expert Opin. Drug Deliv.,2008

5. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice;Biedermann;Nat. Immunol.,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leishmania vaccine development: A comprehensive review;Cellular Immunology;2024-05

2. Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine;Frontiers in Molecular Biosciences;2023-04-21

3. The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis;International Journal of Pharmaceutics;2023-02

4. Anti-leishmanial therapy: Caught between drugs and immune targets;Experimental Parasitology;2023-02

5. Stage-Specific Class I Nucleases of Leishmania Play Important Roles in Parasite Infection and Survival;Frontiers in Cellular and Infection Microbiology;2021-10-15